Literature DB >> 6104060

No cytogenic effect of metronidazole.

F Mitelman, B Strömbeck, B Ursing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6104060     DOI： 10.1016/s0140-6736(80)91706-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Authors:  L Sutherland; J Singleton; J Sessions; S Hanauer; E Krawitt; G Rankin; R Summers; H Mekhjian; N Greenberger; M Kelly
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Antibiotics for induction and maintenance of remission in Crohn's disease.

Authors:  Cassandra M Townsend; Claire E Parker; John K MacDonald; Tran M Nguyen; Vipul Jairath; Brian G Feagan; Reena Khanna
Journal:  Cochrane Database Syst Rev       Date:  2019-02-07

3.  Crohn's disease and leukemia.

Authors:  J A Girón; M Yebra; J J Solovera; L Abreu; J Diego; F Bonilla; A Durántez
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

Review 4.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.